JerMa88/BMC_Womens_Health_Peer_Reviews huggingface dataset:
Title: Endometriosis in an ectopic kidney : A rare case report and literature review
Version: 1 Date: 01 Mar 2023
Reviewer's report:
I read with great interest the manuscript, which falls within the aim of this Journal. In my honest
opinion, the topic is interesting enough to attract the readers’ attention. Nevertheless, the authors
should clarify some points and improve the discussion, as suggested below.
Authors should consider the following recommendations:
- Manuscript should be further revised in order to correct some typos and improve style.
- Accumulating evidence suggests that immune cells, adhesion molecules, extracellular matrix
metalloproteinase and pro-inflammatory cytokines activate/alter peritoneal microenvironment,
creating the conditions for differentiation, adhesion, proliferation and survival of ectopic
endometrial cells. I would discuss these points in the light of new theories about the pathogenesis
of endometriosis, referring to: PMID: 31663401; PMID: 28100109.
- Although peritoneal superficial lesions and ovarian endometriomas represent the majority
of endometriotic implants within the pelvis, deep infiltrating endometriosis and extrapelvic
endometriosis are the most challenging conditions to face off. Despite sometimes medical
therapy is enough to reduce symptoms and signs (PMID: 30074068), in a large number of
patients a complete eradication, with nerve-sparing and vascular sparing approach (PMID:
30415128) is needed to restore the normal pelvic anatomy and its functions. I would add few
lines to discuss these points, referring to the abovementioned works.
Title: Endometriosis in an ectopic kidney : A rare case report and literature review
Version: 1 Date: 06 Mar 2023
Reviewer's report:
Thank you to give me the chance to review this case report;
despite good overall merit, I have some comments to improve the quality of the manuscript:
- please revise english language (eg "endometrial history" in table I should be  "positive history
for endometriosis diagnosis")
- please make mention of other rare locations of extra-abdominal disease, such as nasal
endometriosis (i.e.  doi: 10.1016/j.jmig.2012.03.005)
- please discuss deeper about new insights on pathogenesis of endometriosis (i.e.  doi: 10.1007/
s43032-020-00370-9; doi: 10.1080/09513590.2020.1766440)
- please comment on the chance to have co-occurence of deep infiltrating endometriosis
in the pelvis and its clinical implications, such as dyschezia, dysuria, dyspareunia and
voiding alterations due to neurotrophism and neurotropism (i.e. 10.1016/j.jmig.2014.05.012);
unfourtantely most of the papers considered in the systematic review did not make mention of
other sites of endometriosis and diagnosis of DIE can be omitted in non-specialized center (i.e.
10.1111/aogs.13866).
Title: Endometriosis in an ectopic kidney : A rare case report and literature review
Version: 1 Date: 11 Mar 2023
Reviewer:  Maria Grazia Porpora
Reviewer's report:
This article accurately describes the case of a young women who received diagnosis of ectopic
left kidney endometriosis.
The Abstract is clear, the English language is correct and well spelled, and the topic is very
interesting.
The Discussion is well organized and reports a deep insight into the available evidence on kidney
endometriosis.
References are updated.
Therefore, the article deserves publication in the current form.
Title: Endometriosis in an ectopic kidney : A rare case report and literature review
Version: 3 Date: 08 Apr 2023
Reviewer:  Maria Grazia Porpora
Reviewer's report:
This article accurately describes the case of a young women who received diagnosis of ectopic
left kidney endometriosis.
The Abstract is clear, the English language is correct and well spelled, and the topic is very
interesting.
The Discussion is well organized and reports a deep insight into the available evidence on kidney
endometriosis.
References are updated.
Therefore, the article deserves publication in the current version.
Title: Nomogram to predict FSH starting dose in poor ovarian response women in progestin
primed ovarian stimulation protocol
Version: 2 Date: 24 Oct 2022
Reviewer:  Manal Nasih Ahmed Hamdan
Reviewer's report:
Dear Sir
the manuscript is very interesting and includes a very new subject which is important to deal
with in every clinic working with infertility and IVF  centers.
creating nomogram to decide what dose to start with for each individual  IVF case will solve the
big dilemma of adjusting the required dose of gonadotropin for ovarian stimulation.
Patients with poor responder ovaries add more difficulties in deciding the stated dose.
suppression of the ovaries with progestin will benefit poor responders in improving ovarian
response with the prevention of premature LH surge.
1.the manuscript needs a few Grammarly corrections.
2. in line 114 could you explain the statement:(fertilized in vitro by either FET or ICSI)please?
3. you exclude the age from your research and include AMH, BMI , and AFC  ONLY in
the nomogram as the age has a low p-value while actually, it is a very important indicator in
predicting the success rate in poor responder patients practically. I think you will face a lot of
objections you need more evidence to prove your theory.
4. for me as an IVF specialist found the subject very interesting, and to follow your novel theory
please add some pros and cons to me and to the patient.
for example patient compliance, cost(as it needs frequent investigation and follow-up every 2-3
days and the cost of freezing all embryos  in progestin primed program )
, in comparison with the conventional methods, and if any complication occurs extra.
best regard
Title: Nomogram to predict FSH starting dose in poor ovarian response women in progestin
primed ovarian stimulation protocol
Version: 2 Date: 29 Oct 2022
Reviewer's report:
Comments to the editor
Thank you for the opportunity to review the article titled: Nomogram to predict the FSH starting
dose based on BMI, AMH and AFC in women with poor ovarian response in PPOS
In this study, the authors have used Nomogram to predict the FSH starting dose based on BMI,
AMH and AFC in women with poor ovarian response in PPOS
.They have reached a conclusion that The application of the nomogram based on three variables
easily determined in clinical practice: BMI, AMH and AFC would lead to a more tailored FSH
starting dose in women with poor ovarian.. there are some grammatical errors Throughout the
manuscript. Thus, I think that this paper needs some adjustments and corrections that I have
mentioned below, otherwise I believe that it contains important scientific data which are valuable
for the field.
Specific comments
1. Introduction: ntroduction:first paragraph  line 3 : this sentence isnt clear , omitt the word
(offered)
Introduction :first line of the second paragraph ;  " has been named" the sentence is grammerly
incorrect
Introduction : second line of the third paragraph  use the word "safety" instead of " safe"
Introduction : fifth line of the third paragraph the reference is repeated twice
Introduction : seventh line of the third paragraph "best treatment strategy BASED on"
Introduction : eighth line of the third paragraph needs panctuation,
Introduction : tenth line of the third paragraph the sentence is grammerly incorrect use " and
IT IS  fundamenal" instead
2. Materials and methods for patients and sample collection:
line 115  fertilization by FET and ICSI .as earlier the author described FET as frozen thawed
embryo transfer .please write in details how was the fertilization done in the study group ?do
not you thing it should be same procedure for all the study group to reduce bias?
Line 118  The author did not mentioned in details the freeze all protocol that must be done to
all patients  at what day they did freezing cleavage stage or blast ?there should be some missing
data. Please as this is a vital point in the study please rewrite in details because a you know if
you did ET at blastocyst stage its complete different from cleavage stage and this point might
greatly affect you result and conclusion .
Line 118  Regarding the grading system for cleavage stage and blastocyst stage should
mentioned and cited in the reference section
3. table 1 Demographic characteristics of patients in the study the author mentioned retrieved
oocytes how many mature oocyts that where ready for ICSI and what was the quality of oocytes .
please adda them to the same table
4 . Please the paper needs an English proofreading
Title: Nomogram to predict FSH starting dose in poor ovarian response women in progestin
primed ovarian stimulation protocol
Version: 8 Date: 17 Dec 2022
Reviewer's report:
Comments to the editor
Thank you for the opportunity to review the article titled: Nomogram to predict the FSH starting
dose based on BMI, AMH and AFC in women with poor ovarian response in PPOS.
In this study, the authors have used Nomogram to predict the FSH starting dose based on BMI,
AMH and AFC in women with poor ovarian response in PPOS.I think this paper still needs some
adjustments and corrections that I have mentioned below.
Specific comments
1. Materials and methods for patients and sample collection:
Line 119 : line 119 : you mentioned freezing at cleavage then blastcyst you have to be specific
rewrite this sentence.Please as this is a vital point in the study please rewrite in details because
a you know if you did ET at blastocyst stage its complete different from cleavage stage and this
point might greatly affect you result and conclusion .
2- Add limitations :one of the limitations of the study no follow up outcme implantation and
pregnancy rate as it is retrospective study its easy for the reseascher to add  if he can not add at
least add them to the limitation of this study
3- regardinf the ICSI and IVF I would prefer do separation of data between icsi and ivf as mixing
them can be confusing . if you can not do at least add explanation
4- once you choose conventional fertilization have to add in inclusion criteria that seminal fluid
analysis was normal
Title: Nomogram to predict FSH starting dose in poor ovarian response women in progestin
primed ovarian stimulation protocol
Version: 12 Date: 15 Feb 2023
Reviewer:  Thaer Mahmood Farhan
Reviewer's report:
Dears authors
Actually, it was a great tedious work to achieve such important issue regarding the treatment
of those women poor responder
I will elaborate on
1. explain clearly the definition of the ovarian reserve term with references
2. make use of the international brands of drugs and treatment for accuracy and more specific
effect and to get optimization
3. mention clearly how the AFC is counted ( by Ultrasound or some what else ) I did not find
it clear in the text
apart from above , to my knowledge it is very good work
Title: Nomogram to predict FSH starting dose in poor ovarian response women in progestin
primed ovarian stimulation protocol
Version: 12 Date: 15 Feb 2023
Reviewer:  Fadia J Alizzi
Reviewer's report:
Review of the manuscript (Nomogram to predict the FSH starting dose based on BMI, AMH
and AFC in women with poor ovarian response in PPOS)
Thanks for asking to review the paper & the following points I wish to be considered
1.  Regarding the title :  No abbreviation in the title ; suggested title: Nomogram to predict FSH
starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol
2.  Keyword to be written in alphabet
3.  Better to use grammerly program to ovoid grammar error  seen in the manuscript
4.  You mention in the introduction that (there is no established criteria to select the starting
dose of FSH; actually there is but for poor responder probably not. Preferable to highlight on
this in the introduction.
5.  In methodology :
o  add reference for Bologna criteria
o  2PN abbreviation mentioned for the first time should be full
o  Regarding the protocol, you trigger with agonist and HCG; even in poor responder the protocol
routinely use agonist for trigger?
6.  In the discussion:
o  Discussion is not precise
o  From the aim of the study we thought that the nanogram will be for the poor responder only
& AMH range & AFC number will be within the poor responder range and it shows that it give
limited value above La Marca nanogram at 2013
7.  Recommending to give nanogram for poor responder in the view of AFC & AMH in poor
responder range (AMH less than 1.1 ng/ml & AFC less than 5) and not to include other groups
of women.
8. Recommendition : Major revision
Title: Nomogram to predict FSH starting dose in poor ovarian response women in progestin
primed ovarian stimulation protocol
Version: 14 Date: 24 Mar 2023
Reviewer:  Fadia J Alizzi
Reviewer's report:
Thank you for your replay to my comments points to point
Most of the points had been answered but I wish if there was a real nomogram for poor responder
only and withinin the range of poor responder
Regarding grammerly program its program that correct all the ms automatically
Regards
Title: Factors associated with health-related quality of life in gynaecologic cancer survivors
with lower limb lymphedema: A cross-sectional study in Taiwan
Version: 0 Date: 24 Mar 2023
Reviewer's report:
Dear Authors,
thank you for your interesting article.
I have some minor comments to suggest.
1) Explain all the acronyms in a table to help the readers.
2) Please add in the discussion a proper wide paragraph discussing the potential physical impact
of LLL. For example, you could cite the  pathophysiology of vasculopathy of legs --> cellulitis.
Which could strongly affect quality of life for its aesthetic impact.
3) I would add a proper stratification for age: since the quality of life could be differently be
hampered for very young girls rather than older.
Title: Factors associated with health-related quality of life in gynaecologic cancer survivors
with lower limb lymphedema: A cross-sectional study in Taiwan
Version: 0 Date: 26 Mar 2023
Reviewer:  Violante di Donato
Reviewer's report:
In my opinion, the analyzed topic is interesting enough to attract the readers’ attention.
The aim of this study is to assess the levels of symptom distress, depression, body image,
and health-related quality of life  related to lower limb lymphoedema and to recognize
factors associated with health-related quality of life related to  lower limb lymphoedema in
gynecological cancer survivors with  lower limb lymphoedema .
I think that the abstract of this article is clear. Mabey I think that
an extensive correction of the English should be done.
In my opinion, the discussion could be studied in depth and extended. Maybe, it could be useful
the evaluation of possible indexes which could prevent and predict the  health-related quality
of life of gynecological cancer survivors.  In particular, I suggest these articles to get deeper in
the topic, respectively: PMID: 35793638, The role of preoperative frailty assessment in patients
affected by gynecological cancer: a narrative review
Ottavia D’Oria, Tullio Golia D’Auge, Ermelinda Baiocco, Cristina Vincenzoni, Emanuela
Mancini, Valentina Bruno, Benito Chiofalo, Rosanna Mancari, Riccardo Vizza, Giuseppe
Cutillo, Andrea Giannini
Vol. 34 (No. 2) 2022 June, 76-83
Because of these reasons, the article should be revised and completed.
Considered all these points, I think it could be of interest for the readers and, in my opinion, it
deserves the priority to be published after minor revisions.
Title: Factors associated with health-related quality of life in gynaecologic cancer survivors
with lower limb lymphedema: A cross-sectional study in Taiwan
Version: 0 Date: 27 Mar 2023
Reviewer:  Ilaria Cuccu
Reviewer's report:
In my opinion, this topic analyzed is interesting enough to attract readers’ attention. The goal of
this study is to assess the levels of symptom distress, depression, body image, and health-related
quality of life (HRQoL) related to lower limb lymphoedema (LLL)
I think that the abstract of this article is very clear and well structured.
It could be useful the evaluation of various comorbidity, older age to calculate a score of risk
which could predict possible post-operative surgical outcomes.  (In particular, I suggest this
article to get deeper in the topic PMID: 33223220, 31657456). In this way the discussion should
be more explicative and complete.
Because of these reasons, the article should be revised and completed. Considering all this points,
I think it could be of interest for the readers and, in my opinion, it deserves the priority to be
published after minor revisions.
Title: Factors associated with health-related quality of life in gynaecologic cancer survivors
with lower limb lymphedema: A cross-sectional study in Taiwan
Version: 1 Date: 05 Apr 2023
Reviewer:  Violante di Donato
Reviewer's report:
I wanted to thank the authors for making the requested changes and thus broadening
and clarifying the discussion. I also thank them for English corrections . Thanks to these
modifications the article is much more flowing and clearer and that's why it is deserves the
priority to be published
Title: Factors associated with health-related quality of life in gynaecologic cancer survivors
with lower limb lymphedema: A cross-sectional study in Taiwan
Version: 1 Date: 07 Apr 2023
Reviewer:  Ilaria Cuccu
Reviewer's report:
I wanted to thank the authors who followed the suggestions proposed in the review. I believe
that in this way the work is more complete and more fluid on a linguistic level. Because of this,
I think that it is deserves the priority to be published.
Title: Period poverty and mental health in a representative sample of young women in
Barcelona, Spain
Version: 2 Date: 11 Jan 2023
Reviewer:  Elias Yadeta Debele
Reviewer's report:
The article is well-written and organized. The authors also come up with significant research
findings. Here are some of my concerns for your consideration before publication:
1. I think the authors employed a cross-sectional study design. If it is so the main drawback of
the cross-sectional study is to establish the temporal relations. Is it possible to assess the impact
of period poverty on mental health?
2. My main concern is your sample size determination. You didn’t apply any statistical formula
to estimate the sample size why?
3. Under the material and method section, you stated that the study subjects were 1407 subjects
participated in the study. How did you estimate this sample size? (show your sample size
determination process)
4. You also stated the subjects were selected through a stratified random sampling method: is it
simple random sampling or systematic random sampling? Please specify it.
5. Indicate your exclusion criteria and inclusion criteria.
6. Under the method section of the abstract, please add the study design and sampling method
you used and how the collected data was processed.
7. There are many factors which significantly associated with mental health. Why do the authors
prefer to include only Period poverty in the title of the manuscript?
8. Why not the authors used the AOR to report the significant association of explanatory
variables with the outcome variable?
9. Under the conclusion, it is better if you remove this sentence (For the first time
using quantitative data obtained from a representative sample of the young population our
investigation adds to the very scarce evidence on the severe consequences of experiencing period
poverty by women). You can take it to the last paragraph of the introduction section.
10. Most importantly, the authors need to look in detail at the methodology section. The
methodology section missed important points like the method of data analysis, study population,
inclusion and exclusion criteria, data collection processes, sample size determination, study
design used, etc.
11. The discussion section is fine. It is well written
Title: Period poverty and mental health in a representative sample of young women in
Barcelona, Spain
Version: 2 Date: 16 Jan 2023
Reviewer:  Marzieh Jahani Sayad Noveiri
Reviewer's report:
Thanks to the respected research team
In the abstract, the research method should be mentioned first.
Since the number of words in the abstract is large, it is suggested to shorten the conclusion.
In the background, It is suggested not to focus on the covid epidemic and to save the related
material.
If the author insists on keeping this content, it should be added to the title.
In method It is not clear, how was the sample size determined and how do you explain this
sample drop?
What were the criteria for entering and exiting the study?
Please write down the validity and reliability of the instruments.
Please summarize the last part of the method.
As a result, please talk about individual social variables and refer to table 1.
Page 10, please refer to Table 2 at the end of the sentence.
Please also mention the limitation of the study.
Title: Period poverty and mental health in a representative sample of young women in
Barcelona, Spain
Version: 4 Date: 27 Feb 2023
Reviewer:  Marzieh Jahani Sayad Noveiri
Reviewer's report:
In abstract:
In back ground, the aim should be the end of the paragraph.
Please write your type of study in the first part of the first section of methods
The abstract is too long.
In methods:
At first of the methods,  should be mentioned ,  is a cross-sectional  study
From page 7, the method is very long and needs to be deleted and summarized.
It would be better to report the reliability that you have done yourself
Title: METABOLIC AND BIOCHEMICAL PROFILE IN WOMEN WITH POLYCYSTIC
OVARIAN SYNDROME ATTENDING TERTIARY CARE CENTRE OF CENTRAL
NEPAL
Version: 1 Date: 16 Sep 2022
Reviewer's report:
Major Comments:
Page 3, Introduction. Which standard diagnostic criteria you have followed to diagnose
PCOS??? example:  Rotterdam criteria or national institutes of health criteria.
Page 3, Introduction. The risk factor you have mentioned for PCOS are both risk factors and
complications of PCOS and the reference you have provided for it doesn’t match.
Page 3, Introduction. How does routine laparoscopic evaluation for infertility help in diagnosing
PCOS resulting in the rise of its case? It’s a treatment modality rather than a diagnostic tool.
Page 3, Methodology. A descriptive cross-sectional study is either point prevalence or period
prevalence. Considering the sample size (107 females) it seems to be period prevalence so it's
better to mention the time frame of the study performed.
Page 4, Methodology. What are the criteria for group division you have mentioned? Why do
you want to group the subject on basis of weight as the patient’s distribution among the group
seems quite variable 37% overweight vs 9% obese vs  54% normal weight ??.
Minor Comments:
Page 7, Result. Obesity is a well-known risk factor for hypertension and a well-known
complication of hypothyroidism. So what’s the purpose of the line you have mentioned that
there is increased blood pressure and increased TSH in an obese group??
Page 11, Conclusion. A cross-sectional study is used to make inferences about possible
relationships between cause and effect rather than use them to determine the cause of disease.
So the “ …can lead to reproductive….” Has to be corrected as” it has shown an association with
long-term complications of reproductive….”
Title: METABOLIC AND BIOCHEMICAL PROFILE IN WOMEN WITH POLYCYSTIC
OVARIAN SYNDROME ATTENDING TERTIARY CARE CENTRE OF CENTRAL
NEPAL
Version: 1 Date: 26 Feb 2023
Reviewer:  Naval Kishor Yadav
Reviewer's report:
Conclusion: Rewrite the conclusion based the results.
Provide reference for prevalence in sample size calculation.
Biochemical parameters value and unit is not matching , so check and correct it.